Announcement Date: January 1, 2008
A report published in the Wall Street Journal states that Risperdal may increase male production of prolactin, a hormone that stimulates milk production. The report surfaced after a lawyer representing boys who suffered from gynecomastia filed a lawsuit against Johnson & Johnson.